Literature DB >> 6499693

An epidemiological perspective of sudden death. 26-year follow-up in the Framingham Study.

W B Kannel, D L McGee, A Schatzkin.   

Abstract

Over 26 years of follow-up of 5209 Framingham subjects there were 147 sudden deaths in men and 50 in women. Half the sudden deaths in men and 70% in women occurred without prior coronary heart disease. The incidence doubled with each decade of age, with women lagging men by 20 years. At any age in either sex the risk varied widely in relation to their risk factor make-up. By incorporating systolic pressure, serum cholesterol, vital capacity, cigarette smoking, relative weight, heart rate and ECG abnormalities into a multivariate formulation, a composite estimate of risk was obtained over a wide range. The multivariate sudden death prediction was as efficient in women as in men, identifying 53% and 42% of the sudden deaths, respectively, in the upper decile of multivariate risk. At any level of multivariate risk, women had only a third of the sudden death incidence of men, suggesting a unique biological resistance to sudden death. Ventricular premature beats, associated with an excess sudden death incidence, often occurred concurrently with ECG evidence of left ventricular hypertrophy, intraventricular block, and nonspecific ECG abnormalities. These associated ECG abnormalities were more highly predictive of sudden death than ventricular premature beats. The key to prevention of sudden death would appear to be reduction of the risk of coronary attacks. Once overt coronary heart disease or cardiac failure appears, the risk of sudden death escalates 9-fold, and at this stage the standard coronary heart disease risk factors have little predictive value. Only ECG abnormalities, arrhythmia and poor cardiac function appear to be predictive.

Entities:  

Mesh:

Year:  1984        PMID: 6499693     DOI: 10.2165/00003495-198400281-00002

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  19 in total

1.  Factors related to suddenness of death from coronary disease: combined Albany-Framingham studies.

Authors:  J T Doyle; W B Kannel; P M McNamara; P Quickenton; T Gordon
Journal:  Am J Cardiol       Date:  1976-06       Impact factor: 2.778

2.  Pathology of the heart in sudden cardiac death.

Authors:  D D Reichenbach; N S Moss; E Meyer
Journal:  Am J Cardiol       Date:  1977-05-26       Impact factor: 2.778

3.  Factors influencing long-term prognosis after recovery from myocardial infarction--three-year findings of the coronary drug project.

Authors: 
Journal:  J Chronic Dis       Date:  1974-08

4.  Mechanisms of ventricular arrhythmias associated with myocardial infarction.

Authors:  J Han
Journal:  Am J Cardiol       Date:  1969-12       Impact factor: 2.778

5.  Role of diabetes in congestive heart failure: the Framingham study.

Authors:  W B Kannel; M Hjortland; W P Castelli
Journal:  Am J Cardiol       Date:  1974-07       Impact factor: 2.778

6.  Instantaneous and sudden deaths. Clinical and pathological differentiation in coronary artery disease.

Authors:  M Friedman; J H Manwaring; R H Rosenman; G Donlon; P Ortega; S M Grube
Journal:  JAMA       Date:  1973-09-10       Impact factor: 56.272

7.  Platelet adhesiveness, plasma fibrinogen and factor 8 levels in diabetes mellitus.

Authors:  E E Mayne; J M Bridges; J A Weaver
Journal:  Diabetologia       Date:  1970-08       Impact factor: 10.122

Review 8.  Update on the role of cigarette smoking in coronary artery disease.

Authors:  W B Kannel
Journal:  Am Heart J       Date:  1981-03       Impact factor: 4.749

9.  Reduction in mortality after myocardial infarction with long-term beta-adrenoceptor blockade. Multicentre international study: supplementary report.

Authors: 
Journal:  Br Med J       Date:  1977-08-13

10.  Lipoproteins, cardiovascular disease, and death. The Framingham study.

Authors:  T Gordon; W B Kannel; W P Castelli; T R Dawber
Journal:  Arch Intern Med       Date:  1981-08
View more
  14 in total

1.  Changes in frequency of premature complexes and heart rate variability related to shift work.

Authors:  L G van Amelsvoort; E G Schouten; A C Maan; C A Swenne; F J Kok
Journal:  Occup Environ Med       Date:  2001-10       Impact factor: 4.402

Review 2.  Antiarrhythmic therapies for the prevention of sudden cardiac death.

Authors:  F A McAlister; K K Teo
Journal:  Drugs       Date:  1997-08       Impact factor: 9.546

Review 3.  Risk-benefit assessment of antiarrhythmic drugs. An epidemiological perspective.

Authors:  L Friedman; E Schron; S Yusuf
Journal:  Drug Saf       Date:  1991 Sep-Oct       Impact factor: 5.606

4.  Alcohol intemperance and sudden death.

Authors:  H Lithell; H Aberg; I Selinus; H Hedstrand
Journal:  Br Med J (Clin Res Ed)       Date:  1987-06-06

Review 5.  Gender and cardiac arrhythmias.

Authors:  R P Villareal; A L Woodruff; A Massumi
Journal:  Tex Heart Inst J       Date:  2001

Review 6.  Sudden cardiac death in patients with hypertension. An association with diuretics and beta-blockers?

Authors:  A W Hoes; D E Grobbee; J Lubsen
Journal:  Drug Saf       Date:  1997-04       Impact factor: 5.606

7.  Distinctive profile of sudden cardiac arrest in middle-aged vs. older adults: a community-based study.

Authors:  Amit Noheria; Carmen Teodorescu; Audrey Uy-Evanado; Kyndaron Reinier; Ronald Mariani; Karen Gunson; Jonathan Jui; Sumeet S Chugh
Journal:  Int J Cardiol       Date:  2013-05-17       Impact factor: 4.164

Review 8.  Do non-potassium-sparing diuretics increase the risk of sudden cardiac death in hypertensive patients? Recent evidence.

Authors:  A W Hoes; D E Grobbee; T M Peet; J Lubsen
Journal:  Drugs       Date:  1994-05       Impact factor: 9.546

9.  Cardiac autonomic functions in obese children.

Authors:  Mehmet Emre Taşçılar; Mehmet Yokuşoğlu; Mehmet Boyraz; Oben Baysan; Cem Köz; Ruşen Dündaröz
Journal:  J Clin Res Pediatr Endocrinol       Date:  2011-06-08

10.  Hypertension images: electrocardiographic left ventricular hypertrophy.

Authors:  L M Prisant
Journal:  J Clin Hypertens (Greenwich)       Date:  2001 Nov-Dec       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.